Is PharmAdva, LLC a real, registered company?
PharmAdva, LLC is a registered filer with the SEC (CIK 2067748) and has filed since 2025-05-13. 2 filings are on record, the latest on 2026-01-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
How much has PharmAdva, LLC raised?
Its new offerings report $1.54M sold across 2 offerings, as its own filings state.
Run the free check on PharmAdva, LLC →
ROCHESTER, NEW YORK
Manufacturing
2
$1.54M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-01-23 | New offering first sale 2026-01-21 | $550K | $1M | SEC filing |
| 2025-05-13 | New offering first sale 2025-04-18 | $987K | $1M | SEC filing |
Keep reading
More on PharmAdva, LLC and the records around it.
PharmAdva, LLC elsewhere on the record
- Form D filing Jan 2026
- Form D filing May 2025
Watch PharmAdva, LLC
Get an email when PharmAdva, LLC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with PharmAdva, LLC?
Who to contact
- Jonathan Sacks — Director
- Mark Ambruster — Director
- Michael Allen — Director
- Pamela Schwitzer — Director
- Jim Brush — Director
- Michael Berg — Executive Officer, Director
- Joel Reiser — Director
- Round: Form D filed 2026-01-23
- Amount sold: $550K
- Industry: Manufacturing
- Based: ROCHESTER, NEW YORK
People listed
- Jonathan Sacks — Director
- Mark Ambruster — Director
- Michael Allen — Director
- Pamela Schwitzer — Director
- Jim Brush — Director
- Michael Berg — Executive Officer, Director
- Joel Reiser — Director
- Filing: Form D filed 2026-01-23
- Amount sold: $550K
- Industry group: Manufacturing
- Based: ROCHESTER, NEW YORK
- Entity type: Limited Liability Company
We'll show it in your MentionFox inbox when PharmAdva, LLC raises, hires or launches. No email unless you switch it on.
Watch PharmAdva, LLC →Want the whole picture on PharmAdva, LLC?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on PharmAdva, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on PharmAdva, LLC covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from PharmAdva, LLC's own filings with the SEC. The people those filings name are on the team page.